The “Enteral Feeding Formulas Market” report 2020 covers all the significant developments which are recently being adopted across the global market. The prime objective of the Enteral Feeding Formulas market report is to provides an in-depth analysis of all market dynamics including drivers and restraints, and trends, and opportunities. The Enteral Feeding Formulas market report covers both the demand and supply aspects of the market. The report also highlighted the future trends in the Enteral Feeding Formulas market that will impact the demand during the forecast period.
Scope of the Report:
Enteral feeding refers to the delivery of a nutritionally complete feed, containing protein, carbohydrate, fat, water, minerals, and vitamins, directly into the stomach, duodenum, or jejunum. The report covers various types of polymeric, monomeric, and disease-specific enteral formulas.
Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14098995
Market Overview:
Some of the Top Key Players of Enteral Feeding Formulas Market Report Are:
Report Highlights:
- Market Dynamics – Drivers, Restraints, and Opportunities
- Market Segmentation – Types, Applications, Regions, and Technology
- Market Trends
- Competitive Landscape
- SWOT Analysis and Porter’s Five Forces Analysis
For More Information or Query or Customization Before Buying, Visit at – https://www.industryresearch.co/enquiry/pre-order-enquiry/14098995
Key Market Trends:
By Application, the Oncology Segment is Expected to Register Robust Growth.
Globally, the burden of cancer is growing rapidly. Cancer is one of the leading causes of death across the globe, with 8.8 million victims in 2015, and accounting for nearly one in six deaths. The disease has witnessed significant growth in the last few decades and is expected to grow rapidly during the forecast period. Majority of tumor-bearing patients suffer from cancer cachexia, which causes insulin resistance, increased lipolysis with loss of body fat, increased protein turnover, and loss of muscle mass causing loss of appetite and weight. Furthermore, cancer treatment causes many complications and side effects in the patients, including mucositis sores in the mouth, difficulty in chewing and swallowing solid food, altered saliva level making it difficult to swallow. To improve the clinical condition of cancer patients, providing nutrition is the cornerstone, as it becomes very difficult for the cancer patients to take the food orally, and as the treatment proceeds, the nutrition is supplied by enteral feeding tubes to help them maintain the body mass. The incidence and prevalence of cancer are increasing, contributing to the growth of the enteral feeding formulas market during the forecast period.
The United States Leads the Enteral Feeding Formulas market
North America is expected to dominate the enteral feeding formulas market owing to factors, such as rapid aging population, the surging prevalence of preterm birth, and the rise in the number of chronic disease patients. In the United States, it is projected that the number of people aged above 65 years will more than double till 2060. The rise in the geriatric population will increase the cases of chronic diseases, such as cancer and diabetes which will further lead to an increase in a hospital stay of the patient. In addition, as per the data published by WHO, 15 million babies are born preterm and this number is rising. Hence, all of the above-mentioned factors are expected to drive market growth.
The Report Covers:
- Comprehensive research methodology of Enteral Feeding Formulas market
- In-depth analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global sleep aid market
- Insights about market determinants which are stimulating the global Enteral Feeding Formulas market
- Detailed and extensive market segments with regional distribution of forecasted revenues
- Extensive profiles and recent developments of market players Companies Mentioned
Purchase this Report (Price 4250 USD for single user license) – https://www.industryresearch.co/purchase/14098995
Detailed TOC of Enteral Feeding Formulas Market Report 2020-2024:
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Chronic Diseases
4.2.2 Rising Geriatric Population
4.2.3 High Incidence of Preterm Births
4.3 Market Restraints
4.3.1 Complications Associated with Enteral Nutrition
4.3.2 Patient Safety Risks and Occurrence of Feeding or Medication Errors
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Polymeric
5.1.2 Monomeric
5.1.3 Disease-Specific Formulas
5.2 By Application
5.2.1 Oncology
5.2.2 Neurology
5.2.3 Critical Care
5.2.4 Diabetes
5.2.5 Gastroenterology
5.2.6 Other Applications
5.3 By End User
5.3.1 Hospital
5.3.2 Home Care Agencies and Hospices
5.3.3 Nursing Homes
5.4 Geography
5.4.1 North America
5.4.1.1 US
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 UK
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 B. Braun Melsungen AG
6.1.3 Danone Nutricia
6.1.4 Fresenius Kabi AG
6.1.5 Global Health Product Inc.
6.1.6 Mead Johnson & Company LLC
6.1.7 Meiji Holdings Co., Ltd
6.1.8 Nestle SA
6.1.9 Trovita Health Science
6.1.10 Victus
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Contact Us:
Name: Ajay More
Phone: US +14242530807/ UK +44 20 3239 8187
Email: [email protected]
Our Other Reports:
